Search
Taking a step toward discovering the cause of joint disease
Study finds switches near GDF5 gene linked to knee osteoarthritis, hip dysplasia
Helium microscope for imaging delicate structures gains funding
A Liverpool team are to develop an advanced quantum technology microscope for non-destructive testing
CELLINK launches the S.NEST, a high-throughput microbioreactor
The technology ensures maximum cell growth and streamlined workflows, with real-time monitoring
Eppendorf expands centrifuge portfolio with Himac floor-standing centrifuges
New centrifuge options accommodate speeds up to 110,000 x g and capacities up to six liters
Cresset announces release of new comprehensive molecule design platform Flare V5
Ligand-based technologies integrated into Flare V5 offer a comprehensive molecule design solution for drug discovery research chemists
Triple quadrupole GC/MS application compendium
Beverage testing with the MQuant StripScan mobile app
CyTOF XT: The next generation of mass cytometry
CyTOF XT: The next evolution
World-class speaker lineup announced for Virtual Neuroscience Summit 2021
Register free today to join scientists from around the world as they come together to discuss the hottest topics and latest technology solutions
Take a bite from our Food Contamination: Quality and Safety feature
Explore our curated selection of top food quality and safety resources to bolster your research
Metals digestion detection limits: How low can you go?
Watch this on-demand webinar to stay competitive in the environmental testing market by achieving lower detection limits
Lonza and CN Bio announce distribution agreement providing prevalidated hepatocytes for use on innovative organ-on-a-chip range
The provision of high-quality cells that are known to grow successfully in 3D culture will help fast track organ-on-a-chip (OOC) adoption and customer research
Scientific Laboratory Supplies (SLS) launches SLS Lab Pro gas and liquid nitrogen (LN2) generators
New line of SLS Lab Pro generators put laboratories in control of their gas and liquid nitrogen supplies
Interrogating 3D versus 2D cellular models in drug discovery
Sweetch secures $20 Million Series A to accelerate fully automated hyper-personalized engagement between health ecosystem players and people with chronic conditions
The investment will scale Sweetch’s Just-In-Time-Adaptive-Intervention (JITAI) technology to help each individual adhere to their treatment programs and improve clinical outcomes